Atlas Trials

Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC

Clinical trial NCT05550090 · UNKNOWN

Trial details

NCT number
NCT05550090
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Metastatic Breast Cancer in the Liver
Start date
2022-09-16
Primary completion
2025-09-16
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.